Vaxart Inc (VXRT)
0.5993
-0.01
(-1.40%)
USD |
NASDAQ |
Nov 21, 16:00
0.6051
+0.01
(+0.97%)
Pre-Market: 09:04
Vaxart Profit Margin (Quarterly): -285.4% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -285.4% |
| June 30, 2024 | -257.2% |
| March 31, 2024 | -1.12K% |
| December 31, 2023 | -262.3% |
| September 30, 2023 | -3.90K% |
| June 30, 2023 | -75.17K% |
| March 31, 2023 | -9.04K% |
| December 31, 2022 | -108.7K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -29.53K% |
| December 31, 2021 | -28.06K% |
| September 30, 2021 | -8.79K% |
| June 30, 2021 | -14.39K% |
| March 31, 2021 | -3.16K% |
| December 31, 2020 | -3.89K% |
| September 30, 2020 | -3.05K% |
| June 30, 2020 | -1.72K% |
| March 31, 2020 | -44.69% |
| December 31, 2019 | -163.7% |
| September 30, 2019 | -1.16K% |
| June 30, 2019 | -6.63K% |
| March 31, 2019 | -24.76% |
| December 31, 2018 | -277.4% |
| September 30, 2018 | -2.33K% |
| Date | Value |
|---|---|
| June 30, 2018 | -1.46K% |
| March 31, 2018 | |
| December 31, 2017 | -125.9% |
| September 30, 2017 | -5.30K% |
| June 30, 2017 | -5.90K% |
| March 31, 2017 | -89.80% |
| December 31, 2016 | -239.5% |
| September 30, 2016 | -10.00K% |
| June 30, 2016 | -1.40K% |
| March 31, 2016 | -98.11% |
| December 31, 2015 | -382.4% |
| September 30, 2015 | -388.2% |
| June 30, 2015 | -485.4% |
| March 31, 2015 | 20.34% |
| December 31, 2014 | 46.76% |
| September 30, 2014 | -985.7% |
| June 30, 2014 | -121.4% |
| March 31, 2014 | 10.85% |
| December 31, 2013 | -0.54% |
| September 30, 2013 | -31.71% |
| June 30, 2013 | -72.42% |
| March 31, 2013 | 1.72% |
| December 31, 2012 | 46.50% |
| September 30, 2012 | -647.2% |
| June 30, 2012 | -433.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-108.7K%
Minimum
Dec 2022
-44.69%
Maximum
Mar 2020
-16.20K%
Average
-3.53K%
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -108.5% |
| Return on Assets | -63.84% |
| Return on Invested Capital | -108.5% |
| Operating Margin (Quarterly) | -293.4% |
| Return on Net Operating Assets | -141.9% |